Hybrids of 3α-methoxyserrat-14-en-21β-ol (PJ-1) and 3β-methoxyserrat-14-en-21β-ol (PJ-2) and various anti-oxidants as cancer chemopreventive agents

European Journal of Medicinal Chemistry

Volumn 45, Issue 6, 2010, Pages 2191-2197

  Tsujii, Hiroko ^a   Yamada, Takeshi ^a   Kajimoto, Tetsuya ^a   Tanaka, Reiko ^a   Tokuda, Harukuni ^b   Hasegawa, Junya ^c   Hamashima, Yoshio ^c   Node, Manabu ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

3 Methoxyserrat 14 en 21 ol; 3 Methoxyserrat 14 en 21 ol; Epstein Barr virus early antigen (EBV EA) activation; In vivo two stage mouse skin carcinogenesis test; Quercetin

Indexed keywords

3ALPHA METHOXYSERRAT 14 EN 21BETA OL; 3BETA METHOXYSERRAT 14 EN 21BETA OL; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BAICALEIN; CURCUMIN; EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; KOJIC ACID; OLEANOLIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; QUERCETIN; UNCLASSIFIED DRUG; 3BETA-METHOXYSERRAT-14-EN-21BETA-OL; PYRONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; TRITERPENE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HYBRID; IC 50; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR PROMOTION; ANIMAL; CELL LINE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG ANTAGONISM; DRUG SCREENING; ENZYMOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; NEOPLASM; PATHOLOGY; SKIN TUMOR;

ANIMALS; ANTIGENS, VIRAL; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HERPESVIRUS 4, HUMAN; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MICE; MICE, INBRED ICR; NEOPLASMS; PYRONES; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRITERPENES;

EID: 77950858847     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.01.057     Document Type: Article

References (31)

1. Hong W.K., and Sporn M.B. Science 278 (1997) 1073-1077
2. Sporn M.B. Cancer Res. 59 (1999) 4743-4758
3. Berenblum I. Cancer Res. 1 (1941) 807-814
4. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., and Reddy B.S. Cancer Res. 59 (1999) 597
5. Tanaka R., Shanmugasundaram K., Yamaguchi C., Ishikawa Y., Tokuda H., Nishide K., and Node M. Cancer Lett. 196 (2004) 149-156
6. Tanaka R., Minami T., Tsujimoto K., Matsunaga S., Tokuda H., Nishino H., Terada Y., and Yoshitake A. Cancer Lett. 172 (2001) 119-126
7. Tanaka R., Minami T., Ishikawa Y., Matsunaga S., Tokuda H., and Nishino H. Cancer Lett. 19 (2003) 121-126
8. Tanaka R., Tsujimoto K., In Y., Ishida T., Matsunaga S., Tokuda H., and Muraoka O. Tetrahedron 58 (2002) 2505-2512
9. Tanaka R., Kinouchi Y., Tokuda H., Nishino H., and Matsunaga S. Planta Med. 66 (2000) 630-634
10. Yamaguchi C., Wanibichi H., Kinoshita A., Tanaka R., and Fukushima S. Food Chem. Toxicol. (2008) 1882-1888
11. Strocchi A. Revue Francaise des Corps Gras 35 (1988) 163-168
12. Hong L.M., and Nam H.Y. Planta Med. 69 (2003) 327-331
13. Kawamori T., Tanaka T., Hara A., Yamahara J., and Mori H. Cancer Res. 55 (1995) 1277-1282
14. Senthil S., Sridevi M., and Pugalendi K.V. Toxicol. Mech. Meth. 17 (2007) 57-65
15. Chen L., Zhang Y., Kong X., Lan E., Huang Z., Peng S., Kaufman D.L., and Tian J. J. Med. Chem. 51 (2008) 4834-4838
16. Vasilevsky S.F., Govdi A.I., Shults E.E., Shakirov M.M., Sorokina I.V., Tolstikova T.G., Baev D.S., Tolstikov G.A., and Alabugin I.V. Bioorg. Med. Chem. 17 (2009) 5164-5169
17. Shi Q., Wang H.K., Bastow K.F., Tachibana Y., Chen K., Lee F.Y., and Lee K.H. Bioorg. Med. Chem. 9 (2001) 2999-3004
18. Tietze L., Bell H., and Chandrasekhar S. Angew. Chem. Int. Ed. 42 (2003) 3996-4028
19. Huang M.T., Lysz T., Ferraro T., Abidi T.F., Laskin J.D., and Conney A.H. Cancer Res. 51 (1991) 813-819
20. Takabatake M., Shibutani M., Dewa Y., Nishimura J., Yasuno H., Jin M., Muguruma M., Kono T., and Mitsumori K. J. Toxicol. Sci. 33 (2008) 127-140
21. Nishino H., Naito E., Iwashima A., Tanaka K., Matsuura T., Fujiki H., and Sugimura T. Gann 75 (1984) 311-316
22. Taniguchi H., Yoshida T., Horinaka M., Yasuda T., Goda A.E., Konishi M., Wakada M., Kataoka K., Yoshikawa T., and Sakai T. Cancer Res. 68 (2008) 8918-8927
23. Iveson P., and Parke D.V. J. Chem. Soc. C. (1970) 2038-2042
24. Baltina L.A. Curr. Med. Chem. 17 (2003) 155-171
25. Tatsuzaki J., Taniguchi M., Bastow K.F., Nakagawa-Goto K., Morris-Natschke S.L., Itokawa H., Baba K., and Lee K.-H. Bioorg. Med. Chem. 15 (2007) 6193-6199
26. Ma C.-M., Nakamura N., Hattori M., Kawahata T., and Otake T. Chem. Pharm. Bull. 50 (2002) 877-880
27. Tanaka R., Tsujii H., Yamada T., Kajimoto T., Amano F., Hasegawa J., Hamashima Y., Node M., Katoh K., and Takebe Y. Bioorg. Med. Chem. 17 (2009) 5238-5246
28. Tokuda H., Ohigashi H., Koshimizu K., and Ito Y. Cancer Lett. 33 (1986) 279-285
29. Tanaka R., Mun C., Usami Y., and Matsunaga S. Phytochemistry 35 (1994) 1517-1522
30. Ito Y., Kawanishi M., Harayama T., and Takabayashi S. Cancer Lett. 12 (1981) 175-180
31. Henle G., and Henle W. J. Bacteriol. 91 (1966) 1248-1256